IAEA Director General Meets President of Syria and Agrees on New Engagement with Syria and Increased Cancer Care Support

Today in Damascus, #Syria, I visited Al-Bairouni Hospital and announced @IAEAorg's support to the country through #RaysOfHope: we're providing Al-Bairouni and Tishreen hospitals with essential equipment to improve cancer detection and treatment in 🇸🇾. pic.twitter.com/dvN2m4DyFN

— Rafael MarianoGrossi (@rafaelmgrossi) March 19, 2024

Syria’s national cancer control capacities were assessed in late 2022 by the IAEA and its partners in an imPACT Review. The review found that Syria, like many other middle-income countries in the Arab world, is facing a significant increase in the occurrence of cancer cases. Cancer cases and deaths are expected to double between 2020 and 2030. Childhood cancers make up around five to 10 per cent of the cancer burden in the country, with approximately 1500 new cases each year.

Cancer is too often detected late or at an advanced stage in Syria, presenting a formidable challenge for healthcare providers. The 2022 imPACT review concluded that this cancer burden could be alleviated by early detection schemes, particularly for breast and prostate cancers.

Syria has two well-equipped paediatric oncology centres with multidisciplinary cancer care that treat more than 50 per cent of paediatric cancer patients in the country. However, many children do not complete the recommended treatment due to drug shortages and service disruptions.

An increase in childhood cancers is coupled with limited access to diagnostic imaging, radiotherapy and nuclear medicine, due to shortages of equipment and technology as well as an inadequate workforce and heavy workloads.

The 2022 review recommended that a national action plan be developed for Syria and implemented with IAEA and WHO support — including the development of a cancer registry and surveillance tools, the establishment of a national radiotherapy programme and the implementation of accredited training programmes in diagnostic imaging and nuclear medicine.

The IAEA delivered support totalling €1.75 million to Syria following the devastating earthquake in February 2023. This support included medical equipment  including portable and mobile X ray machines, non-destructive testing devices and portable ultrasound units.

The IAEA and partners will also supply medical equipment to improve long term healthcare capabilities at two hospitals in Syria. Two X ray units, and two CT scanners will be provided to Al Razi Hospital and Aleppo University Hospital to enhance diagnostic capabilities.

Aiding recovery and rebuilding efforts, the IAEA organized a workshop on non-destructive testing (NDT) equipment in May 2023 for local engineers and scientists with assistance from the Atomic Energy Commission of Syria. NDT is used to detect damage in buildings affected by earthquakes. Participants enhanced their knowledge of NDT equipment, provided by the IAEA, and benefited from the expertise of international experts.

A follow-up IAEA workshop is planned for June 2024. It is intended to strengthen and increase the existing capacity in Syria to use NDT. This will enable Syrian experts to assist in future disaster recovery efforts in the region.